Developing and bringing to market effective Ebola vaccines requires extreme measures and unprecedented international cooperation, global health experts said. In an interim report on a roadmap for vaccines against the current and any future outbreaks of the deadly virus, infectious disease specialists Jeremy Farrar and Mike Osterholm said the scope of effort was “too complex for any single government, organization or company”. They called for sustained public-private sector partnership and commitment. “To bring Ebola vaccines to market, which is clearly in the greater common good given the global consequences of this epidemic, extreme measures are needed to ensure a massive coordinated effort among vaccine manufacturers, government regulatory authorities, government public health agencies, non-governmental organizations and global, national and local leaders,” they wrote. Several potential vaccines are being fast-tracked through development in the hope that one or more may prove able to be used in the world’s largest Ebola outbreak in West Africa. Latest World...
π Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!




